SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-013394
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:40
Documents
74
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1223_lucyscientific.htm   iXBRL 10-Q 999283
2 CERTIFICATION f10q1223ex31-1_lucysci.htm EX-31.1 9886
3 CERTIFICATION f10q1223ex31-2_lucysci.htm EX-31.2 10887
4 CERTIFICATION f10q1223ex32-1_lucysci.htm EX-32.1 3917
5 CERTIFICATION f10q1223ex32-2_lucysci.htm EX-32.2 3713
  Complete submission text file 0001213900-24-013394.txt   5641664

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lsdi-20231231.xsd EX-101.SCH 57398
7 XBRL CALCULATION FILE lsdi-20231231_cal.xml EX-101.CAL 40069
8 XBRL DEFINITION FILE lsdi-20231231_def.xml EX-101.DEF 278910
9 XBRL LABEL FILE lsdi-20231231_lab.xml EX-101.LAB 541217
10 XBRL PRESENTATION FILE lsdi-20231231_pre.xml EX-101.PRE 296942
76 EXTRACTED XBRL INSTANCE DOCUMENT f10q1223_lucyscientific_htm.xml XML 577629
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41616 | Film No.: 24627555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)